Back to news archive
Image for All-time high in QuickMIC® abstracts at ECCMID 2024
News 2024-02-02

All-time high in QuickMIC® abstracts at ECCMID 2024

Gradientech is thrilled to announce that six QuickMIC® abstracts will be presented at the 34th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Barcelona, Spain 27-30 April 2024.

ECCMID, organised by the European Society of Clinical Microbiology and Infectious Diseases, is the world’s premier meeting place for clinical microbiologists and infectious disease specialists, gathering over 14,000 delegates yearly.

This year, six abstracts with data from independent European studies will demonstrate that QuickMIC displays highly accurate results compared to state-of-the-art antibiotic susceptibility testing (AST) solutions on the market. The studies have been performed by various leading European hospital laboratories based in markets with different antibiotic resistance situations. The large number of studies and solid results will further strengthen the case of QuickMIC being the premier rapid AST system on the market.

Read the full press release here.

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book